Biggest News Aggregation in the World
📰 Abarca Forward News

Abarca Forward News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Abarca Forward. Real-time updates on events, politics, business and more.

What Do Payers Need to Help Value-Based Contracting Deals for Novel Therapies Succeed?

A panel discussion at the annual Abarca Forward conference in Puerto Rico last month sought to identify some of the innovative financial approaches that can be applied to managing the high price of novel therapies. Conversations also addressed what payers need for these financing models to be sustainable.
Puerto Rico David Mclean Girisha Fernando Kali Panagos Tank At Tufts University Therapy Solutions

Q&A: As Congressional Heat Builds on PBMs, What Is the Message From the Industry Lobby?

The largest six pharmacy benefit managers are being scrutinized by the Federal Trade Commission, while Congress is debating the Pharmacy Benefit Transparency Act. Meanwhile, states have their own ideas for reining in what they see as excesses of the industry. With all this heat, what is the message from the head of the Pharmaceutical Care Management Association?
United States Puerto Rico Katie Adams Arundhati Parmar Unitedhealthcare Optum Abarca Health

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Medicare Drug Negotiation Is the Model for the Future of Drug Pricing, Abarca CEO Says

For the first time ever, CMS is preparing to negotiate prices for drugs paid for by Medicare. This has sparked a huge debate — will the creation of this taxpayer-funded drug negotiation infrastructure be a failed experiment, or will it become the standard for the future of drug pricing in this country? Jason Borschow, president and CEO of Abarca Health, says it's the latter.
Puerto Rico United States Jason Borschow Katie Adams Arundhati Parmar Abarca Health

What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions

Panelists at a recent pharmacy conference were optimistic about the future of value-based drug contracting. For example, one said that healthcare will be close to establishing a value-based formulary by 2030, and another said that longitudinal patient tracking will become a more important part the drug pricing process.
Puerto Rico Kali Panagos Katie Adams David Mclean Arundhati Parmar Girisha Fernando

Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons

Panelists at a recent healthcare conference expressed optimism about the automation technology that health plans, pharmacy benefit managers and providers can adopt to facilitate real-time data sharing. They said that such technology has potential to improve medication adherence, reduce costs and save time for both providers and payers.
Puerto Rico Katie Adams Arundhati Parmar David Cutler April Todd Scott Rochowiak

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science